Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):314-324
Tumor necrosis factor (TNF)-blocking agents are one of the new option in the treatment of immune-mediated inflammatory diseases, such as rheumatoid arthritis, Crohn disease, ulcerative colitis. However, anti-TNF therapy is associated with the …